drugset

drugset / Trial / NCT00372255

Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years

NCT00372255 ↗

Phase 4 Completed 240 enrolled GlaxoSmithKline

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The study will evaluate the immune response and the tolerability of the influenza vaccine administered in children aged 6-13 years old.

Timeline

Start: 2005-11-17
Primary completion: 2006-03-28
Completion: 2006-03-28

Publications

Background Schmidt-Ott R, Schwarz T, Haase R, Sander H, Walther U, Fourneau M, Htun-Myint L, Sanger R, Schuster V. Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years. Vaccine. 2007 Dec 21;26(1):32-40. doi: 10.1016/j.vaccine.2007.10.049. Epub 2007 Nov 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Influsplit SSW® 2005/2006	Unknown	—	Intramuscular

Indications